Introduction: X-linked lymphoproliferative syndrome (XLP) is a rare primary immune deficiency. Two types of XLP have been described: XLP-1 and XLP-2. Methods: We found 7 patients with XLP (3 had XLP-1 and 4 had XLP-2) after reviewing the data from Pediatric Immunodeficiency Clinic from 1997 to 2021. Results: Mean age at diagnosis was 3.8 years, and mean delay in diagnosis was 2.6 years. Five patients had recurrent episodes of infections. Four patients developed at least one episode of hemophagocytic lymphohistiocytosis (HLH) (2 with XLP-1 and 2 with XLP-2). Of these, 2 had recurrent HLH (both with XLP-2). Epstein-Barr virus (EBV) infection was detected in 2 (1 with XLP-1 and 1 with XLP-2). Both these patients had HLH. One child with XLP-2 had inflammatory bowel disease. Hypogammaglobulinemia was seen in 3 (2 with XLP-1 and 1 with XLP-2). Genetic analysis showed previously reported variants in 5, while 2 had novel variants (one in exon 7 of XIAP gene [c.1370dup p.Asn457Lysfs Ter16] and other had splice site variant in intron 1 of SH2D1A gene [c.138-2_138-1insG]). Episodes of HLH were managed with intravenous immunoglobulin (IVIg), methylprednisolone, oral prednisolone, cyclosporine, and rituximab. Inflammatory bowel disease was managed using oral prednisolone and azathioprine. One patient underwent haploidentical hematopoietic stem cell transplantation. One child with XLP-2 and WAS died because of fulminant pneumonia. Discussion/Conclusions: XLP should be considered as a strong possibility in any patient with features of HLH, repeated infections with hypogammaglobulinemia, persistent EBV infection, and early-onset IBD.

1.
Purtilo
DT
,
Cassel
CK
,
Yang
JP
,
Harper
R
.
X-linked recessive progressive combined variable immunodeficiency (Duncan’s disease)
.
Lancet
.
1975
;
1
(
7913
):
935
40
.
2.
Coffey
AJ
,
Brooksbank
RA
,
Brandau
O
,
Oohashi
T
,
Howell
GR
,
Bye
JM
et al
.
Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene
.
Nat Genet
.
1998
;
20
(
2
):
129
35
.
3.
Rigaud
S
,
Fondanèche
MC
,
Lambert
N
,
Pasquier
B
,
Mateo
V
,
Soulas
P
et al
.
XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome
.
Nature
.
2006
;
444
(
7115
):
110
4
.
4.
Purtilo
DT
,
Grierson
HL
.
Methods of detection of new families with X-linked lymphoproliferative disease
.
Cancer Genet Cytogenet
.
1991
;
51
(
2
):
143
53
.
5.
Sumegi
J
,
Huang
D
,
Lanyi
A
,
Davis
JD
,
Seemayer
TA
,
Maeda
A
et al
.
Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease
.
Blood
.
2000
;
96
(
9
):
3118
25
.
6.
Hamilton
JK
,
Paquin
LA
,
Sullivan
JL
,
Maurer
HS
,
Cruzi
FG
,
Provisor
AJ
et al
.
X-linked lymphoproliferative syndrome registry report
.
J Pediatr
.
1980
;
96
(
4
):
669
73
.
7.
Howie
D
,
Sayos
J
,
Terhorst
C
,
Morra
M
.
The gene defective in X-linked lymphoproliferative disease controls T cell dependent immune surveillance against Epstein-Barr virus
.
Curr Opin Immunol
.
2000
;
12
(
4
):
474
8
.
8.
Spickett
GP
,
Farrant
J
,
North
ME
,
Zhang
JG
,
Morgan
L
,
Webster
AD
.
Common variable immunodeficiency: how many diseases
.
Immunol Today
.
1997
;
18
(
7
):
325
8
.
9.
Cunningham-Rundles
C
,
Bodian
C
.
Common variable immunodeficiency: clinical and immunological features of 248 patients
.
Clin Immunol
.
1999
;
92
(
1
):
34
48
.
10.
Morra
M
,
Silander
O
,
Calpe
S
,
Choi
M
,
Oettgen
H
,
Myers
L
et al
.
Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency syndrome
.
Blood
.
2001
;
98
(
5
):
1321
5
.
11.
Soresina
A
,
Lougaris
V
,
Giliani
S
,
Cardinale
F
,
Armenio
L
,
Cattalini
M
et al
.
Mutations of the X-linked lymphoproliferative disease gene SH2D1A mimicking common variable immunodeficiency
.
Eur J Pediatr
.
2002
;
161
(
12
):
656
9
.
12.
Dutz
JP
,
Benoit
L
,
Wang
X
,
Demetrick
DJ
,
Junker
A
,
de Sa
D
et al
.
Lymphocytic vasculitis in X-linked lymphoproliferative disease
.
Blood
.
2001
;
97
(
1
):
95
100
.
13.
Purtilo
DT
,
Grierson
HL
,
Davis
JR
,
Okano
M
.
The X-linked lymphoproliferative disease: from autopsy toward cloning the gene 1975-1990
.
Pediatr Pathol
.
1991
;
11
(
5
):
685
710
.
14.
Purtilo
DT
,
DeFlorio
D
,
Hutt
LM
,
Bhawan
J
,
Yang
JP
,
Otto
R
et al
.
Variable phenotypic expression of an X-linked recessive lymphoproliferative syndrome
.
N Engl J Med
.
1977
;
297
(
20
):
1077
80
.
15.
Okano
M
,
Gross
TG
.
Epstein-Barr virus-associated hemophagocytic syndrome and fatal infectious mononucleosis
.
Am J Hematol
.
1996
;
53
(
2
):
111
5
.
16.
Seemayer
TA
,
Grierson
H
,
Pirruccello
SJ
,
Gross
TG
,
Weisenburger
DD
,
Davis
J
et al
.
X-linked lymphoproliferative disease
.
Am J Dis Child
.
1993
;
147
(
11
):
1242
5
.
17.
Pachlopnik Schmid
J
,
Canioni
D
,
Moshous
D
,
Touzot
F
,
Mahlaoui
N
,
Hauck
F
et al
.
Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency)
.
Blood
.
2011
;
117
(
5
):
1522
9
.
18.
Marsh
RA
,
Madden
L
,
Kitchen
BJ
,
Mody
R
,
McClimon
B
,
Jordan
MB
et al
.
XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease
.
Blood
.
2010
;
116
(
7
):
1079
82
.
19.
Parolini
S
,
Bottino
C
,
Falco
M
,
Augugliaro
R
,
Giliani
S
,
Franceschini
R
et al
.
X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells
.
J Exp Med
.
2000
;
192
(
3
):
337
46
.
20.
Booth
C
,
Gilmour
KC
,
Veys
P
,
Gennery
AR
,
Slatter
MA
,
Chapel
H
et al
.
X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease
.
Blood
.
2011
;
117
(
1
):
53
62
.
21.
Lankester
AC
,
Visser
LFA
,
Hartwig
NG
,
Bredius
RGM
,
Gaspar
HB
,
van der Burg
M
et al
.
Allogeneic stem cell transplantation in X-linked lymphoproliferative disease: two cases in one family and review of the literature
.
Bone Marrow Transpl
.
2005
;
36
(
2
):
99
105
.
22.
Marsh
RA
,
Bleesing
JJ
,
Chandrakasan
S
,
Jordan
MB
,
Davies
SM
,
Filipovich
AH
.
Reduced-intensity conditioning hematopoietic cell transplantation is an effective treatment for patients with SLAM-associated protein deficiency/X-linked lymphoproliferative disease type 1
.
Biol Blood Marrow Transplant
.
2014
;
20
(
10
):
1641
5
.
23.
Loganathan
A
,
Munirathnam
D
,
Sundaram
B
.
X-Linked lymphoproliferative disease (XLP1) presenting as non-epstein barr virus (EBV): related hemophagocytic lymphohistiocytosis (HLH)
.
Indian Pediatr
.
2020
;
57
(
11
):
1077
8
.
24.
Bhattarai
D
,
Vignesh
P
,
Kaur
A
,
Kumari
P
,
V Menon
J
,
Geethanjali
G
et al
.
Epstein-Barr virus-associated lymphocytic cholangitis in a child with X-linked lymphoproliferative syndrome
.
Scand J Immunol
.
2021
;
93
(
2
):
e12975
.
25.
Richards
S
,
Aziz
N
,
Bale
S
,
Bick
D
,
Das
S
,
Gastier-Foster
J
et al
.
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology
.
Genet Med
.
2015
;
17
(
5
):
405
24
.
26.
Xu
T
,
Zhao
Q
,
Li
W
,
Chen
X
,
Xue
X
,
Chen
Z
et al
.
X-linked lymphoproliferative syndrome in mainland China: review of clinical, genetic, and immunological characteristic
.
Eur J Pediatr
.
2020
;
179
(
2
):
327
38
.
27.
Yang
X
,
Wang
J
,
An
YF
,
Kanegane
H
,
Miyawaki
T
,
Zhao
XD
.
[Genetic and proteinic analysis of a Chinese boy with X-linked lymphoproliferative disease and his maternal relatives]
.
Zhonghua Er Ke Za Zhi
.
2011
;
49
(
6
):
416
20
.
28.
Arkwright
PD
,
Makin
G
,
Will
AM
,
Ayres
M
,
Gokhale
DA
,
Fergusson
WD
et al
.
X linked lymphoproliferative disease in a United Kingdom family
.
Arch Dis Child
.
1998
;
79
(
1
):
52
5
.
29.
Ma
CS
,
Hare
NJ
,
Nichols
KE
,
Dupré
L
,
Andolfi
G
,
Roncarolo
MG
et al
.
Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells
.
J Clin Invest
.
2005
;
115
(
4
):
1049
59
.
30.
Qi
H
,
Cannons
JL
,
Klauschen
F
,
Schwartzberg
PL
,
Germain
RN
.
SAP-controlled T-B cell interactions underlie germinal centre formation
.
Nature
.
2008
;
455
(
7214
):
764
9
.
31.
Crotty
S
,
Kersh
EN
,
Cannons
J
,
Schwartzberg
PL
,
Ahmed
R
.
SAP is required for generating long-term humoral immunity
.
Nature
.
2003
;
421
(
6920
):
282
7
.
32.
Krieg
A
,
Correa
RG
,
Garrison
JB
,
Le Negrate
G
,
Welsh
K
,
Huang
Z
et al
.
XIAP mediates NOD signaling via interaction with RIP2
.
Proc Natl Acad Sci USA
.
2009
;
106
(
34
):
14524
9
.
33.
Hugot
JP
,
Chamaillard
M
,
Zouali
H
,
Lesage
S
,
Cézard
JP
,
Belaiche
J
et al
.
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease
.
Nature
.
2001
;
411
(
6837
):
599
603
.
34.
Latour
S
,
Winter
S
.
Inherited immunodeficiencies with high predisposition to epstein-barr virus-driven lymphoproliferative diseases
.
Front Immunol
.
2018
;
9
:
1103
.
35.
Shapiro
RS
,
Chauvenet
A
,
McGuire
W
,
Pearson
A
,
Craft
AW
,
McGlave
P
et al
.
Treatment of B-cell lymphoproliferative disorders with interferon alfa and intravenous gamma globulin
.
N Engl J Med
.
1988
;
318
(
20
):
1334
.
36.
Snow
AL
,
Marsh
RA
,
Krummey
SM
,
Roehrs
P
,
Young
LR
,
Zhang
K
et al
.
Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency
.
J Clin Invest
.
2009
;
119
(
10
):
2976
89
.
37.
Bagulkar
BB
,
Gawande
M
,
Chaudhary
M
,
Gadbail
AR
,
Patil
S
,
Bagulkar
S
.
XIAP and ki-67: a correlation between antiapoptotic and proliferative marker expression in benign and malignant tumours of salivary gland: an immunohistochemical study
.
J Clin Diagn Res
.
2015
9
2
EC01
04
.
38.
Elenitoba-Johnson
KS
,
Jaffe
ES
.
Lymphoproliferative disorders associated with congenital immunodeficiencies
.
Semin Diagn Pathol
.
1997
;
14
(
1
):
35
47
.
39.
Gadoury-Levesque
V
,
Dong
L
,
Su
R
,
Chen
J
,
Zhang
K
,
Risma
KA
et al
.
Frequency and spectrum of disease-causing variants in 1892 patients with suspected genetic HLH disorders
.
Blood Adv
.
2020
;
4
(
12
):
2578
94
.
40.
Damgaard
RB
,
Fiil
BK
,
Speckmann
C
,
Yabal
M
,
zur Stadt
U
,
Bekker-Jensen
S
et al
.
Disease-causing mutations in the XIAP BIR2 domain impair NOD2-dependent immune signalling
.
EMBO Mol Med
.
2013
;
5
(
8
):
1278
95
.
41.
Aguilar
C
,
Lenoir
C
,
Lambert
N
,
Bègue
B
,
Brousse
N
,
Canioni
D
et al
.
Characterization of Crohn disease in X-linked inhibitor of apoptosis-deficient male patients and female symptomatic carriers
.
J Allergy Clin Immunol
.
2014
;
134
(
5
):
1131
41.e9
.
42.
Ono
S
,
Okano
T
,
Hoshino
A
,
Yanagimachi
M
,
Hamamoto
K
,
Nakazawa
Y
et al
.
Hematopoietic stem cell transplantation for XIAP deficiency in Japan
.
J Clin Immunol
.
2017
;
37
(
1
):
85
91
.
43.
Yang
J
,
Zhu
GH
,
Wang
B
,
Zhang
R
,
Jia
CG
,
Yan
Y
et al
.
Haploidentical hematopoietic stem cell transplantation for XIAP deficiency: a single-center report
.
J Clin Immunol
.
2020
;
40
(
6
):
893
900
.
44.
Chellapandian
D
,
Das
R
,
Zelley
K
,
Wiener
SJ
,
Zhao
H
,
Teachey
DT
et al
.
Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens
.
Br J Haematol
.
2013
;
162
(
3
):
376
82
.
45.
Sacco
KA
,
Notarangelo
LD
,
Delmonte
OM
.
When to suspect inborn errors of immunity in Epstein-Barr virus-related lymphoproliferative disorders
.
Clin Microbiol Infect
.
2023
;
29
(
4
):
457
62
.
46.
Kanegane
H
,
Ito
Y
,
Ohshima
K
,
Shichijo
T
,
Tomimasu
K
,
Nomura
K
et al
.
X-linked lymphoproliferative syndrome presenting with systemic lymphocytic vasculitis
.
Am J Hematol
.
2005
;
78
(
2
):
130
3
.
47.
Sun
J
,
Ying
W
,
Liu
D
,
Hui
X
,
Yu
Y
,
Wang
J
et al
.
Clinical and genetic features of 5 Chinese patients with X-linked lymphoproliferative syndrome
.
Scand J Immunol
.
2013
;
78
(
5
):
463
7
.
48.
An
YF
,
Luo
XB
,
Yang
X
,
Wang
J
,
Li
L
,
Zhao
XD
.
Clinical and molecular characteristics of Chinese patients with X-linked lymphoproliferative syndrome type 1
.
Pediatr Blood Cancer
.
2014
;
61
(
11
):
2043
7
.
49.
Jin
YY
,
Zhou
W
,
Tian
ZQ
,
Chen
TX
.
Variable clinical phenotypes of X-linked lymphoproliferative syndrome in China: report of five cases with three novel mutations and review of the literature
.
Hum Immunol
.
2016
;
77
(
8
):
658
66
.
You do not currently have access to this content.